Navigation Links
ISPE End-to-End Supply Chain Conference - Stepping up Pharmaceutical Operations

Brussels, Belgium (PRWEB) May 02, 2013

ISPE announced today that it will hold a conference on key challenges and opportunities in the pharmaceutical supply chain in Prague on 13-14 June 2013. This two-day event will cover critical-to-success factors in pharmaceutical supply chain management in investigational products and the commercial supply chain. Topics covered during the conference will include investigational product management / logistics, the commercial supply chain integrity and cargo risks. Special focus will be given to the EU GDP and GCP legislation and the Falsified Medicines Directive.

Jim McKiernan, CEO, McKiernan Associates, conference chair said, “The industry has made tremendous strides forward in the past decade to improve its supply chain efficiency. However, compared with other sectors, pharma still has a long way to go to achieve truly world-class performance. This conference will allow attendees to hear examples of best practice and gain insights on moving their business forward, as presented by leading practitioners and regulators.”

Esther Sadler-Williams, Senior Director, Catalent Pharma solutions and conference co-chair added, “The conference is organised by industry experts for experts and includes separate tracks specific to IP and supply chain. We will be covering key topics that explore the needs of our ultimate customer – the patient.”

The conference will provide a unique opportunity for supply chain and production plant managers, clinical supply professionals, CROs, CMOs, anti-counterfeiting officers and tech transfer specialists to be updated on the latest technological and regulatory developments in pharmaceutical supply chain operations. In total, more than 30 industry and regulatory speakers from organizations such as MHRA, NHS Scotland, Napp, Boehringer Ingelheim and Cemafroid, will share their knowledge and experience.

For more information on this conference, including detailed agendas and registration information, visit

About ISPE
ISPE, the International Society for Pharmaceutical Engineering is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit for more information.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Future of Pre- and Probiotics to be Discussed by Kibow Biotech Founder During SupplySide MarketPlace 2013 Global Expo & Conference
2. Michigan's Exotic Automation & Supply Celebrates 50th Anniversary
3. New Webinar on Sensor-based Logistics for Life Science Supply Chains, Hosted by Xtalks
4. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
5. EtQ to Host Life Science Summit on the World of Quality and Global Supply Chain
6. Michigan’s Exotic Automation & Supply to Exhibit at the 2013 Work Truck Show & Green Truck Summit
7. Reliable electric power supply for the energy turn-around
8. Verify Brand Enhances VB Enterprise Platform for Greater Supply Chain Security Across Industries
9. High Voltage Power Supply Manufacturer Holds Annual Food Drive to Fight Local Hunger
10. WHEATON® Acquires Chromatography Vial Supply Company, MicroLiter
11. Ryan Herco Flow Solutions Acquires Expert Piping Supply, Inc.
Post Your Comments:
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... , November 25, 2015 ... Research Report is a professional and in-depth study ...      (Logo: ) , ... of the industry including definitions, classifications, applications and ... provided for the international markets including development trends, ...
(Date:11/24/2015)... HILLS, N.J. (PRWEB) , ... November 24, 2015 , ... ... as the recipient of the 2016 USGA Green Section Award. Presented annually since 1961, ... golf through his or her work with turfgrass. , Clarke, of Iselin, ...
(Date:11/24/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended September 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of iCo ... value enriching for this clinical program, but also ...
Breaking Biology Technology:
(Date:11/17/2015)... 2015 Paris , ... --> Paris , qui s,est tenu ... le leader de l,innovation biométrique, a inventé le premier ... empreintes sur la même surface de balayage. Jusqu,ici, deux ... pour les empreintes digitales. Désormais, un seul scanner est ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
Breaking Biology News(10 mins):